Search results
Cancer Drugs: Deals and Licensing for Antibody-Drug Conjugates
The National Law Review· 2 days agoAntibody-drug conjugates (ADCs) are a promising class of cancer treatments with an accelerating...
COVID shots should target variants with JN.1 lineage in 2024-25 campaign, US FDA advisers say By...
Investing.com· 3 days agoCOVID shots should target variants with JN.1 lineage in 2024-25 campaign, US FDA advisers say
US FDA advisers to consider if new COVID shots should target JN.1 variant
Reuters via Yahoo News· 5 days agoShares of Novavax soared 11% in morning trade, after the documents were released. The company had...
COVID shots should target variants with JN.1 lineage in 2024-25 campaign, US FDA advisers say
Colorado Springs Gazette· 3 days agoThe 16 advisors did not vote on whether to favor the original JN.1 variant or one of its successors...
FDA advisers: Next COVID shots should target variants with JN.1 lineage | Honolulu Star-Advertiser
Honolulu Star-Advertiser· 3 days agoAdvisers to the U.S. Food and Drug Administration today unanimously voted in favor of recommending...
COVID shots should target JN.1 variant in fall 2024 campaign, US FDA says
Colorado Springs Gazette· 12 hours agoThe Food and Drug Administration's advisory is in line with European and World Health Organization recommendations and comes after the agency's advisers on Wednesday overwhelmingly backed the ...
What's Going On With Novavax Stock? - Novavax (NASDAQ:NVAX)
Benzinga· 2 days agoNovavax shares have gained nearly 40% over the past five days, boosted by COVID-19 headlines....
COVID Shots for JN.1 Variant Neutralize Newer Strains, Vaccine Makers Say
US News & World Report· 3 days agoFood and Drug Administration's advisers on Wednesday. The FDA panel will vote to recommend if companies should target the JN.1 variant when the companies update their vaccines for 2024-25 immunization ...
US FDA advisers to consider if new COVID shots should target JN.1 variant
Colorado Springs Gazette· 5 days agoShares of Novavax soared 11% in morning trade, after the documents were released. The company had...
From immunotherapy to mRNA vaccines – the latest science on melanoma treatment explained
The Conversation· 3 days agoMore than 16,000 Australians will be diagnosed with melanoma each year. Over the past decade, these treatments have seen a significant climb in the number of advanced melanoma patients surviving ...